Alzheimer's Disease as a Neurovascular Inflammatory Disorder

Alzheimer's Disease as a Neurovascular Inflammatory Disorder is organized by The New York Academy of Sciences and would be held on Dec 6, 2016 at The New York Academy of Sciences, New York, United States of America.

Description
Growing evidence supports a role for neurovascular inflammation as a major factor in Alzheimer's Disease (AD) onset and progression. However, the scientific community has yet to label AD a vascular disease and questions remain about the viability of neurovascular inflammation as a potential therapeutic target. This symposium will evaluate clinical and preclinical data, and discuss critical barriers to understanding how to clinically test vascular-based hypotheses for the treatment of AD